 |
Molika Ashford is a GenomeWeb contributing editor and covers personalized medicine and molecular diagnostics. E-mail Molika Ashford. |
PCGP Study Finds Potential Drug Targets in Medulloblastoma Subgroups; Highlights Role of Epigenetics
July 03, 2012
PCGP Study Finds Potential Drug Targets in Medulloblastoma Subgroups; Highlights Role of Epigenetics
Full-text access for premium subscribers only.
Existing premium subscribers login here.
New to GenomeWeb? Register here quickly.
New to GenomeWeb? Register here quickly.
Related Stories
- At AACR, Early Providers of NGS-based Cancer Panels Debate 'Actionable' Mutations, Regulatory Issues
April 10, 2013 / Clinical Sequencing News - Sequencing, Though Not Always a Slam Dunk, Gains Traction in Genomic Medicine
March 13, 2013 / Clinical Sequencing News - Sequencing Studies Lead to New Clinical Trial for Overlooked HER2 Mutations in Breast Cancer
December 12, 2012 / Clinical Sequencing News - PCGP Releases Genome Sequence Data for Hundreds of Tumor-Normal Pairs
May 29, 2012 / GenomeWeb Daily News - AACR Presentation Highlights Potential of Profiling Telomere Alterations in Pediatric Cancers Using WGS Data
April 4, 2012 / GenomeWeb Daily News